A test that uses a single drop of blood to determine if a person has Alzheimer’s disease could become available to the general public by next year, a group of Hong Kong scientists have said.

Researchers from the Hong Kong University of Science and Technology (HKUST) revealed the progress of the project on Wednesday, adding that they were also doing preclinical trials on primates to develop a treatment for the neurodegenerative disease through genome-editing technology.